-
COVID Vaccine: How Effective Are They Against Variants?
Key Points: In today’s Recommendations for Industry, we discuss how well the various COVID vaccines work against the variants. Read more below. The CDC estimates that, until now, about “60% of adults and 75% of children” have antibodies indicating that they’ve been infected with COVID-19 (CNN). Moderna has asked the FDA to authorize its vaccine…
-
COVID Levels – Follow the Curve
Key Points: In today’s Recommendations for Industry, we discuss following the curve. Read more below. Extending TSA mask mandate ‘absolutely’ still on the table. On Monday, a top White House COVID-19 adviser said that extending the federal mask mandate for all transportation networks, which is set to expire April 18, is “absolutely” under consideration. Centers…
-
New England Cases Rise – What’s It Really Mean?
Key Points: In today’s Recommendations for Industry, we discuss what the COVID case increase in the New England States means for the U.S. Read more below. New England states are reporting a sharp increase in daily COVID-19 cases driven by the Omicron subvariant, BA.2. This rise in numbers (up to and over 40% in cases)…
-
U.S. Seeing Only a Blip in Cases Despite BA.2 Dominance
Key Points: In today’s Recommendations for Industry, we discuss the “blip” in U.S. COVID cases, despite the fact that BA.2 has become the dominant variant. Read more below. FDA Authorizes Second Booster for Older and Immunocompromised Individuals. FDA authorized a second booster dose of either the Pfizer-BioNTech or the Moderna COVID-19 vaccines for older people…
-
Symptom Monitoring Key to Limiting Workplace Transmissible Disease
Key Points: In today’s Recommendations for Industry, we discuss the ongoing need for symptom monitoring. Read more below. The CDC will extend its mask-use on public transportation order until April 18, 2022. It does not seem that the U.S. will be ending testing rules for international travelers coming into the states (The Points Guy). In…
-
All Signs Show a “Return to Normal” Ahead
Key Points: In today’s Recommendations for Industry, we discuss a return to normal. Read more below. In a recent paper published in JAMA Neurology, CIDRAP cites that in patients over 60 years old who had developed severe illness, “cognitive impairment” post-COVID was common, a year later. The study cohort were those “released from hospitals in…
-
COVID Transitional Period Increases Masking Debate
Key Points: In today’s Recommendations for Industry, we discuss the current “transition” status of COVID-19, mask mandates, and recommendations. Read more below. Is the Coronavirus in Your Backyard?. A study of white-tailed deer killed by hunters or car crashes found more than 60 percent to be infected with COVID-19, showing that deer could become a…
-
Even Unrelated Vaccines Can Help Protect Against COVID-19
Key Points: In today’s Recommendations for Industry, we discuss new studies suggesting that flu shots, measles vaccines, and the common cold can cross-protect against COVID. Read more below. A recently published study found that SARS-CoV-2 infection during pregnancy is associated with an increased risk for adverse pregnancy outcomes, including induced abortion, cesarean sections, preterm birth…
-
Yes, Omicron is Here but No Need for Panic
Key Points: In today’s Recommendations for Industry, we discuss the Omicron variant. Read more below. On Sunday Jan 09, the CDC updated its “Quarantine and Isolation” webpage to allow readers to better understand what to do. The updates have extra charts for readers to better understand when to test and when traveling can be allowed.…
-
Managing Your Workforce in the Omicron Spread and Shortened Recommendations
Key Points: In today’s Recommendations for Industry, we discuss CDC’s COVID updates in which it recommends shortening isolation from 10 days for people with COVID-19 to five days, if asymptomatic, followed by five days of wearing a mask when around others. CDC also now recommends five days quarantine followed by strict mask use for an…